(S)-6-Amino-2-(2-amino-acetylamino)-hexanoic acid

ID: ALA420061

Chembl Id: CHEMBL420061

Cas Number: 997-62-6

PubChem CID: 3080576

Max Phase: Preclinical

Molecular Formula: C8H17N3O3

Molecular Weight: 203.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Gly-Lys | Glycyllysine|Glycyl-L-lysine|Gly-lys|997-62-6|L-Lysine, glycyl-|Glycyl-Lysine|SC93X84LZ9|L-Lysine, N2-glycyl-|UNII-SC93X84LZ9|CHEMBL420061|CHEBI:73909|Glycinyl-L-lysine|Gly-L-Lys|(2S)-6-amino-2-[(2-aminoacetyl)amino]hexanoic acid|SCHEMBL1455499|DTXSID50244215|GK|BDBM50188513|AKOS030607624|HY-113736|CS-0063063|(S)-6-Amino-2-(2-amino-acetylamino)-hexanoic acid|Q27144235

Canonical SMILES:  NCCCC[C@H](NC(=O)CN)C(=O)O

Standard InChI:  InChI=1S/C8H17N3O3/c9-4-2-1-3-6(8(13)14)11-7(12)5-10/h6H,1-5,9-10H2,(H,11,12)(H,13,14)/t6-/m0/s1

Standard InChI Key:  IKAIKUBBJHFNBZ-LURJTMIESA-N

Alternative Forms

  1. Parent:

    ALA420061

    Glycyllysine

Associated Targets(Human)

ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CPA3 Tchem Mast cell carboxypeptidase A (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC15A1 Tchem Oligopeptide transporter small intestine isoform (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACE Angiotensin-converting enzyme (2863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc15a2 Oligopeptide transporter, kidney isoform (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc15a1 Solute carrier family 15 member 1 (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 203.24Molecular Weight (Monoisotopic): 203.1270AlogP: -1.36#Rotatable Bonds: 7
Polar Surface Area: 118.44Molecular Species: ZWITTERIONHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.80CX Basic pKa: 10.21CX LogP: -4.16CX LogD: -4.89
Aromatic Rings: Heavy Atoms: 14QED Weighted: 0.38Np Likeness Score: 0.44

References

1. Collantes ER, Dunn WJ..  (1995)  Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues.,  38  (14): [PMID:7629809] [10.1021/jm00014a022]
2. Ishchenko AV, Shakhnovich EI..  (2002)  SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.,  45  (13): [PMID:12061879] [10.1021/jm0105833]
3. Vig BS, Stouch TR, Timoszyk JK, Quan Y, Wall DA, Smith RL, Faria TN..  (2006)  Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.,  49  (12): [PMID:16759105] [10.1021/jm0511029]
4. Wang Z, Zhang S, Jin H, Wang W, Huo J, Zhou L, Wang Y, Feng F, Zhang L..  (2011)  Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.,  46  (8): [PMID:21621881] [10.1016/j.ejmech.2011.05.007]
5. Terada T, Sawada K, Irie M, Saito H, Hashimoto Y, Inui K..  (2000)  Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.,  440  (1): [PMID:11007306] [10.1007/s004240000339]